Background Chronic inflammation has been associated with sarcopenia and its components
skeletal muscle strength and muscle mass. The aim of this systematic review and meta …

Low-grade inflammation is the hallmark of metabolic disorders such as obesity, type 2
diabetes and nonalcoholic fatty liver disease. Emerging evidence indicates that these …

Objective To present a comprehensive review of the association between measures of body
weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes …

Circulating adiponectin concentrations are reduced in obese individuals, and this reduction
has been proposed to have a crucial role in the pathogenesis of atherosclerosis and …

Even though type 2 diabetes mellitus (T2DM) represents a worldwide chronic health issue
that affects about 462 million people, specific underlying determinants of insulin resistance …

Metabolic syndrome (MetS) describes a cluster of cardio-metabolic factors that predispose to
type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD). While …

Aims There has been growing evidence that adiponectin, tumor necrosis factor-α (TNF-α)
and inflammatory cytokines involved in insulin resistance and may be attractive candidates …

There is increasing evidence showing that inflammation is an important pathogenic mediator
of the development of obesity-induced insulin resistance. It is now generally accepted that …

OBJECTIVE There has been growing evidence that inflammatory markers play a role in the
development of type 2 diabetes. We aimed to systematically review prospective studies on …

Obesity is a public health problem that has reached epidemic proportions with an increasing
worldwide prevalence. The global emergence of obesity increases the risk of developing …